Rated 2.0 / 5 (How Ratings Work)
Possible to probable range of efficacy of cannabis for treatment of neurodegeneration (in general).
Based on 10 Studies from 2003 - 2017
Study Name, Description & Year
Rating
Plastic And Neuroprotective Mechanisms Involved In The Therapeutic Effects Of Cannabidiol In Psychiatric Disorders
Review — 2017
The Cannabinoid Beta-caryophyllene (BCP) Induces Neuritogenesis In PC12 Cells By A Cannabinoid-receptor-independent Mechanism
Laboratory test — 2016
Cannabidiol Reduces Neuroinflammation And Promotes Neuroplasticity And Functional Recovery After Brain Ischemia.
Animal study (mice) — 2016
Cannabinoids In Neurodegenerative Disorders And Stroke/Brain Trauma: From Preclinical Models To Clinical Applications
Review — 2015
THC Prevents MDMA Neurotoxicity In Mice
Animal study (mice) — 2010
Selective CB2 Receptor Agonism Protects Central Neurons From Remote Axotomy-induced Apoptosis Through The PI3K/Akt Pathway
Laboratory — 2009
Comparison Of Cannabidiol, Antioxidants, And Diuretics In Reversing Binge Ethanol-induced Neurotoxicity
Animal study (rats) — 2005
US Patent 6630507: Cannabinoids As Antioxidants And Neuroprotectants
In vitro and in vivo laboratory — 2003
US Patent 6630507: Cannabinoids As Antioxidants And Neuroprotectants
Animal study — 2003
US Patent 6630507: Cannabinoids As Antioxidants And Neuroprotectants
Human study — 2003